Plant Engineering M+W to Design and Build Merck's New Pharmaceutical Facility in China

Editor: Dominik Stephan

Engineering and construction company M*W Group will oversee the design and engineering for a new pharmaceutical facility of Merck in China. The site with around 40,000 square meters is located in the Nantong Economical Technological Development area in the Greater Shanghai region.

Related Vendors

(Picture: Ernhofer/PROCESS)

Shanghai/PR China – M+W Group will be responsible for the engineering design, procurement, construction management and validation services of the factory including production and support buildings. The new facility is designed to manufacture multiple types of dry forms of Oral Solid Dosage (OSD) in their final packaging for the Chinese market, with focus on Merck's leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders. Production capacity is planned to reach over two billion tablets per year in the first phase, going operational by the end of 2016. The total building area has about 38,000 square meters, with the production building (23,000 square meters) as well as the warehouse and logistics building (9,000 square meters) taking up the most space. Both are dedicated to high level cGMP (current Good Manufacturing Practice) activities. Other buildings will house the central utilities, the fire fighting pump station, canteen and offices.

Dr. Olaf Berlien, CEO of M+W Group, about this new order: "We are pleased that this new pharmaceutical facility will not only strengthen Merck's presence in China, but will also contribute to covering China's growing healthcare needs in important areas like diabetes, cardiovascular diseases and thyroid disorders."

Find more plant engineering projects worldwide in our online database GROAB